Larry J Merlo
CIK 1194413 · President and CEO · last filed 2026-05-26
Larry J Merlo is a President and CEO who has filed 57 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for KVUE, was dated May 26, 2026. Across all open-market trades the lifetime net is −$184.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $59.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CVS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
WOONSOCKET, RI 02895
Holdings By Company
Recent Filings
57 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | KVUE | Grant (A) | — | $0 | EDGAR |
| 2025-05-27 | KVUE | Grant (A) | — | $0 | EDGAR |
| 2024-05-28 | KVUE | Grant (A) | — | $0 | EDGAR |
| 2023-08-25 | KVUE | Grant (A) | — | $0 | EDGAR |
| 2021-06-02 | CVS | Tax (F) | −634 | -$54.8K | EDGAR |
| 2021-04-02 | CVS | Mixed | +89,841 | -$6.07M | EDGAR |
| 2021-03-29 | CVS | Mixed | +697 | -$67.3K | EDGAR |
| 2021-01-21 | CVS | Mixed | +1,457 | -$62.2K | EDGAR |
| 2020-04-07 | CVS | Tax (F) | −9,803 | -$546.2K | EDGAR |
| 2020-04-07 | CVS | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.